For patients here in the commonwealth and across the country, we’re on the cusp of a new era in cancer care — one that could ...

Strand Life Sciences secures Indian patent for early cancer detection platform using cfDNA analysis from a single blood ...

Patented platform uses cell-free DNA analysis and machine learning to detect cancer early and identify tissue of origin from ...

The patented platform combines genome sequencing, methylation analysis and machine learning to detect cancer and identify its ...

Medicine is rapidly evolving from statistical, evidence-based approaches to predictive, genotype-directed care, driven by ...

Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection technology ...

A machine learning program that identified patients overdue for colorectal cancer screening helped increase screening rates ...

Reliance’s Strand Life Sciences patents a blood-based technology for early cancer detection, enhancing accuracy and accessibility.

In a significant breakthrough for cancer diagnostics, Reliance Industries subsidiary Strand Life Sciences has secured an Indian patent for an artificial intelligence-powered technology that can detect ...

Researchers at Mayo Clinic have developed an artificial intelligence (AI) system that could transform how pancreatic cancer ...

Multiomics data integration with machine learning has become the standard approach for combining genomic, transcriptomic, proteomic, and metabolomic measurements collected from the same biological ...

Colorectal cancer is associated with certain microbiomes that produce microbial signatures that can be detected by a ...